sb 203580 has been researched along with 15-hydroxy-5,8,11,13-eicosatetraenoic acid in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (15-hydroxy-5,8,11,13-eicosatetraenoic acid) | Trials (15-hydroxy-5,8,11,13-eicosatetraenoic acid) | Recent Studies (post-2010) (15-hydroxy-5,8,11,13-eicosatetraenoic acid) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 742 | 13 | 110 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giribaldi, G; Khadjavi, A; Prato, M; Valente, E | 1 |
1 other study(ies) available for sb 203580 and 15-hydroxy-5,8,11,13-eicosatetraenoic acid
Article | Year |
---|---|
Involvement of p38 MAPK in haemozoin-dependent MMP-9 enhancement in human monocytes.
Topics: Cell Adhesion; Female; Hemeproteins; Humans; Hydroxyeicosatetraenoic Acids; Imidazoles; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Matrix Metalloproteinase 9; Monocytes; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Phosphorylation; Pigments, Biological; Plasmodium falciparum; Protein Serine-Threonine Kinases; Pyridines | 2014 |